Skip to main content
Top
Published in: BMC Gastroenterology 1/2011

Open Access 01-12-2011 | Research article

The actin-bundling protein Fascin is overexpressed in inflammatory bowel disease and may be important in tissue repair

Authors: David Qualtrough, Katie Smallwood, David Littlejohns, Massimo Pignatelli

Published in: BMC Gastroenterology | Issue 1/2011

Login to get access

Abstract

Background

Fascin is associated with increased cell motility in colorectal tumours but is absent from the normal colonic epithelium. We examined the expression of fascin in inflammatory bowel disease (IBD) and its location at regions undergoing restitution and regeneration. Tissue repair is essential for disease remission and we sought to determine the effects of therapeutic modalities on fascin expression and function using an in vitro model.

Methods

Immunohistochemistry was performed on colonic tissue from IBD patients to determine changes in fascin expression and distribution. A human colorectal epithelial cell line was treated with 5-aminosalicylate (a common treatment for IBD), or sodium butyrate to determine the effect on fascin expression and cell motility.

Results

Fascin overexpression was observed in both ulcerative colitis and Crohn's colitis and expression correlated with disease severity. Immunoreactivity was more intense and widespread in Crohn's compared to ulcerative colitis. Interestingly, highly expressing foci were consistently observed at the edges of ulcers where flattened, motile epithelial cells are actively involved in restitution, and also in areas of mucosal regeneration.
5-aminosalicylate reduced fascin expression in colorectal epithelial cells and inhibited their motility. Conversely, sodium butyrate increased fascin expression and stimulated cell motility in the same cells.

Conclusions

Our data shows that fascin is overexpressed in inflammatory bowel disease and its location is indicative of a role in tissue repair. Our in vitro studies show that different therapeutic modalities may have converse effects on fascin expression and may have significant consequences for disease remission and the clinical management of IBD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fiocchi C: Inflammatory Bowel Disease: Etiology and Pathogenesis. Gastroenterology. 1998, 115: 182-205.CrossRefPubMed Fiocchi C: Inflammatory Bowel Disease: Etiology and Pathogenesis. Gastroenterology. 1998, 115: 182-205.CrossRefPubMed
2.
go back to reference Munkholm P: The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003, 18 (S2): 1-5.CrossRefPubMed Munkholm P: The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003, 18 (S2): 1-5.CrossRefPubMed
3.
go back to reference Eaden J: Colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004, 20 (S4): 24-30.CrossRefPubMed Eaden J: Colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004, 20 (S4): 24-30.CrossRefPubMed
4.
go back to reference MacDonald TT, Monteleone G: Immunity, inflammation, and allergy in the gut. Science. 2005, 307: 1920-1925.CrossRefPubMed MacDonald TT, Monteleone G: Immunity, inflammation, and allergy in the gut. Science. 2005, 307: 1920-1925.CrossRefPubMed
5.
go back to reference Okamoto R, Watanabe M: Cellular and molecular mechanisms of the epithelial repair in IBD. Dig Dis Sci. 2005, 50: S34-S38.CrossRefPubMed Okamoto R, Watanabe M: Cellular and molecular mechanisms of the epithelial repair in IBD. Dig Dis Sci. 2005, 50: S34-S38.CrossRefPubMed
6.
go back to reference Hanauer SB: The long-term management of ulcerative colitis. Aliment Pharmacol Ther. 2004, 20 (S4): 97-101.CrossRefPubMed Hanauer SB: The long-term management of ulcerative colitis. Aliment Pharmacol Ther. 2004, 20 (S4): 97-101.CrossRefPubMed
7.
go back to reference Allgayer H: Mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther. 2003, 18 (S2): 10-14.CrossRefPubMed Allgayer H: Mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther. 2003, 18 (S2): 10-14.CrossRefPubMed
8.
go back to reference Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H: Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992, 103: 51-56.CrossRefPubMed Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H: Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992, 103: 51-56.CrossRefPubMed
9.
go back to reference Wächterhäuser A, Stein J: Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr. 2000, 39: 164-171.CrossRef Wächterhäuser A, Stein J: Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr. 2000, 39: 164-171.CrossRef
10.
go back to reference Rombeau JL, Kripke SA, Settle RG: Short chain fatty acids; production, absorption, metabolism and intestinal effects. Dietary Fiber: chemistry, physiology and health effects. Edited by: Kretchevsky D, Bonfield C, Anderson JW. 1990, New York: Plenum Press, 317-37.CrossRef Rombeau JL, Kripke SA, Settle RG: Short chain fatty acids; production, absorption, metabolism and intestinal effects. Dietary Fiber: chemistry, physiology and health effects. Edited by: Kretchevsky D, Bonfield C, Anderson JW. 1990, New York: Plenum Press, 317-37.CrossRef
11.
go back to reference Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJG, Pignatelli M, Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Path. 2003, 162: 69-80.CrossRefPubMedPubMedCentral Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJG, Pignatelli M, Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Path. 2003, 162: 69-80.CrossRefPubMedPubMedCentral
12.
go back to reference Qualtrough D, Singh K, Banu N, Paraskeva C, Pignatelli M: The actin bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro. Br J Cancer. 2009, 101: 1124-1129.CrossRefPubMedPubMedCentral Qualtrough D, Singh K, Banu N, Paraskeva C, Pignatelli M: The actin bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro. Br J Cancer. 2009, 101: 1124-1129.CrossRefPubMedPubMedCentral
13.
go back to reference Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G, Adams JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer. 2006, 6: 241-CrossRefPubMedPubMedCentral Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G, Adams JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer. 2006, 6: 241-CrossRefPubMedPubMedCentral
14.
go back to reference Fogh J, Trempe G: New human tumour cell lines. Human tumour cells in vitro. Edited by: Fogh J. 1975, New York: Plenum Press, 115-141.CrossRef Fogh J, Trempe G: New human tumour cell lines. Human tumour cells in vitro. Edited by: Fogh J. 1975, New York: Plenum Press, 115-141.CrossRef
15.
go back to reference Qualtrough D, Hinoi T, Fearon E, Paraskeva C: Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system. Gut. 2002, 51: 184-90.CrossRefPubMedPubMedCentral Qualtrough D, Hinoi T, Fearon E, Paraskeva C: Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system. Gut. 2002, 51: 184-90.CrossRefPubMedPubMedCentral
16.
go back to reference Qualtrough D, Kaidi A, Chell S, Jabbour HN, Williams AC, Paraskeva C: Prostaglandin F2(alpha) stimulates motility and invasion in colorectal tumour cells. Int J Cancer. 2007, 121: 734-740.CrossRefPubMedPubMedCentral Qualtrough D, Kaidi A, Chell S, Jabbour HN, Williams AC, Paraskeva C: Prostaglandin F2(alpha) stimulates motility and invasion in colorectal tumour cells. Int J Cancer. 2007, 121: 734-740.CrossRefPubMedPubMedCentral
17.
go back to reference Grothey A, Hashizume R, Hong J, Tubb BE, Patrick CW, Yu D, Mooney EE, McCrea PD: C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene. 2000, 19: 4864-4875.CrossRefPubMed Grothey A, Hashizume R, Hong J, Tubb BE, Patrick CW, Yu D, Mooney EE, McCrea PD: C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene. 2000, 19: 4864-4875.CrossRefPubMed
18.
go back to reference Reinacher-Schick RA, Schoeneck A, Graeven U, Schwartze-Waldhoff I, Schmiegel W: Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis. 2003, 24: 443-451.CrossRefPubMed Reinacher-Schick RA, Schoeneck A, Graeven U, Schwartze-Waldhoff I, Schmiegel W: Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis. 2003, 24: 443-451.CrossRefPubMed
19.
go back to reference van Staa TP, Card T, Logan RF, Leufkens HGM: 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. 2005, 54: 1573-1578.CrossRefPubMedPubMedCentral van Staa TP, Card T, Logan RF, Leufkens HGM: 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. 2005, 54: 1573-1578.CrossRefPubMedPubMedCentral
20.
go back to reference Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA, Riddell RH, Rutter MD, Ullman TA, Velayos FS, Itzikowitz S: Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a review and update. Inflammatory Bowel Disease. 2007, 13: 1-10.CrossRef Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA, Riddell RH, Rutter MD, Ullman TA, Velayos FS, Itzikowitz S: Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a review and update. Inflammatory Bowel Disease. 2007, 13: 1-10.CrossRef
21.
go back to reference Wayne K, Stadelmann MD, Alexander G, Digenis MD, Gordon R, Tobin MD: Impediments to Wound Healing. Am J Surg. 1998, 176 (Suppl 2A): 39S-47S. Wayne K, Stadelmann MD, Alexander G, Digenis MD, Gordon R, Tobin MD: Impediments to Wound Healing. Am J Surg. 1998, 176 (Suppl 2A): 39S-47S.
22.
go back to reference Baumgart DC, Vierziger K, Sturm A, Wiedenmann B, Dignass AU: Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. Scand J Gastroenterol. 2005, 40: 958-964.CrossRefPubMed Baumgart DC, Vierziger K, Sturm A, Wiedenmann B, Dignass AU: Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. Scand J Gastroenterol. 2005, 40: 958-964.CrossRefPubMed
23.
go back to reference Butt AJ, Hague A, Paraskeva C: Butyrate-but not TGFβ1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatise. Cell Death Diff. 1997, 4: 725-732.CrossRef Butt AJ, Hague A, Paraskeva C: Butyrate-but not TGFβ1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatise. Cell Death Diff. 1997, 4: 725-732.CrossRef
24.
go back to reference Hague A, Manning AM, Hanlon KA, Huschtsha LI, Hart D, Paraskeva C: Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53 independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int J Cancer. 1993, 55: 498-505.CrossRefPubMed Hague A, Manning AM, Hanlon KA, Huschtsha LI, Hart D, Paraskeva C: Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53 independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int J Cancer. 1993, 55: 498-505.CrossRefPubMed
25.
go back to reference Wilson AJ, Gibson PR: Short chain fatty acids promote the migration of colonic epithelial cells in vitro. Gastroenterology. 1997, 113: 487-496.CrossRefPubMed Wilson AJ, Gibson PR: Short chain fatty acids promote the migration of colonic epithelial cells in vitro. Gastroenterology. 1997, 113: 487-496.CrossRefPubMed
Metadata
Title
The actin-bundling protein Fascin is overexpressed in inflammatory bowel disease and may be important in tissue repair
Authors
David Qualtrough
Katie Smallwood
David Littlejohns
Massimo Pignatelli
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2011
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-11-14

Other articles of this Issue 1/2011

BMC Gastroenterology 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.